Posaconazole

Suppliers

Names

[ Name ]:
Posaconazole

[Synonym ]:
2,5-Anhydro-1,3,4-trideoxy-2-(2,4-difluorophenyl)-4-({4-[4-(4-{1-[(2S,3S)-2-hydroxy-3-pentanyl]-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl}phenyl)-1-piperazinyl]phenoxy}methyl)-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol
2,5-Anhydro-1,3,4-trideoxy-2-(2,4-difluorophenyl)-4-({4-[4-(4-{1-[(2S,3S)-2-hydroxypentan-3-yl]-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl}phenyl)piperazin-1-yl]phenoxy}methyl)-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol
D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-
Pcz
EINECS 200-659-6
Noxafil
HYDROXYPROPYL]-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE
Posaconazole for research
T6N DNTJ AR D- DT5NNVJ BY2&YQ1&& DR DO1- DT5OTJ BR BF DF& B1- AT5NN DNJ &&Stereoisomer
Pos
2,5-Anhydro-1,3,4-trideoxy-2-(2,4-difluorophenyl)-4-({4-[4-(4-{1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl}phenyl)piperazin-1-yl]phenoxy}methyl)-1-(1H-1,2,4-triazol-1-yl)-D-threo-pentitol
4-{4-[4-(4-{[(3R,5R)-5-(2,4-difluorophényl)-5-(1H-1,2,4-triazol-1-ylméthyl)tétrahydrofuran-3-yl]méthoxy}phényl)pipérazin-1-yl]phényl}-2-[(1S,2S)-1-éthyl-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
4-{4-[4-(4-{[(3R,5R)-5-(2,4-Difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2-[(1S,2S)-1-ethyl-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one
Posconazole
Posaconazole

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
850.7±75.0 °C at 760 mmHg

[ Melting Point ]:
170-1720C

[ Molecular Formula ]:
C₃₇H₄₂F₂N₈O₄

[ Molecular Weight ]:
700.777

[ Flash Point ]:
468.3±37.1 °C

[ Exact Mass ]:
700.329712

[ PSA ]:
115.70000

[ LogP ]:
2.25

[ Vapour Pressure ]:
0.0±0.3 mmHg at 25°C

[ Index of Refraction ]:
1.658

[ Storage condition ]:
-20°C Freezer

Safety Information

[ Symbol ]:

GHS02, GHS06, GHS08

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H225-H301 + H311 + H331-H370

[ Precautionary Statements ]:
P210-P260-P280-P301 + P310-P311

[ Hazard Codes ]:
F,T

[ Risk Phrases ]:
11-23/24/25-39/23/24/25

[ Safety Phrases ]:
S61

[ RIDADR ]:
NONH for all modes of transport

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

O-Benzyl Posaconazole
4-Bromophenol
(3S,3aS,7S,7aR)-7-methyl-3-phenylperhydro-isoindole-1,5-dione
2-((2S,3S)-2-(benzyloxy)pentan-3-yl)-4-(4-(piperazin-1-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
(2S,3R)-2-((benzyloxy)methoxy)pentan-3-ol
2-Chloro-2',4'-difluoroacetophenone
1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine

DownStream

Articles

In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.

Antimicrob. Agents Chemother. 58(8) , 4604-11, (2014)

Candida krusei is an important agent of opportunistic infections that often displays resistance to several antifungals. We describe here the in vivo acquisition of resistance to voriconazole (VRC) by ...

European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.

Eur. J. Clin. Microbiol. Infect. Dis. 33(9) , 1623-30, (2014)

In order to better understand the epidemiology of fusariosis in Europe, a survey collecting information on the clinical characteristics of the patients infected by Fusarium as well as on the infecting...

Simultaneous determination of seven azole antifungal drugs in serum by ultra-high pressure liquid chromatography and diode array detection.

Acta Clin. Belg. 69(1) , 53-61, (2014)

Azole antifungals are a group of fungistatic agents that can be administered orally or parenterally. The determination of the concentrations of these antifungals (miconazole, fluconazole, ketoconazole...

posaconazole
Posaconazole-D4
Posaconazole-D5
Posaconazole hydrate
Posaconazole inter-8
O-Benzyl Posaconazole
2,7-diethyl-3H-pyrazolo[1,5-b][1,2,4]triazole
10h-Chromeno[3,2-c]pyridine
4,4,5,5-Tetramethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butoxy]-1,3,2-dioxaborolane
2-(Cyclopentyloxy)pyridin-3-amine
Tert-butyl 4-(4-(dimethylcarbamoyl)benzyl)piperidine-1-carboxylate
2-[2-(4-bromo-3-methylphenyl)-3-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]-4,4-dimethyl-5H-1,3-oxazole
Propyl I+/--aminobenzenebutanoate
Bicyclo[1.1.1]pentan-1-yl(phenyl)methanol
Fmoc-aeg(h)-oh hydrochloride
Ethyl pyrrolo[1,2-a]pyrimidine-7-carboxylate

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.